Hearscape
Therapies database

Find a therapy. Follow the evidence.

See what is being studies, who is developing it, and how far it has progressed.

Search therapy records

Search a therapy, company, target, indication, or trial ID. Narrow by approach, stage, or status, then open a record to check its sources.

More filters and sort (1 active)
3 results
Rincell-1 by Rinri Therapeutics
Rinri Therapeutics · Cell Therapy · Phase 1/2
ActiveTherapeuticStronger sources
Population
Adults · 18–74 years
Cochlear-implant candidates with presbycusis or auditory neuropathy
Evidence
trial
Confidence
92%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing LossAuditory Neuropathy
Details
ACOU085 by Acousia Therapeutics
Acousia Therapeutics GmbH · Small Molecule · Phase 2
ActiveTherapeuticStronger sources
Population
Adults · 18–45 years
Testicular cancer receiving high-dose cisplatin
Evidence
company
Confidence
93%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing LossCisplatin-Induced Hearing Loss
Details
AOK-1
Boehringer Ingelheim · Regenerative Medicine · Preclinical
ActiveTherapeuticStronger sources
Population
Adults · Not yet defined (preclinical)
Noise- or age-related cochlear hair-cell loss
Evidence
company
Confidence
82%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing LossNoise-Induced Hearing Loss
Details

A listing is not proof of safety or effectiveness. Approval and availability may vary by indication and country.

How records are checked